De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors

Tomas Hornak,Jiri Mayer,Petra Cicatkova,Lukas Semerad,Anezka Kvetkova, Hana Klamova,Edgar Faber,Petra Belohlavkova,Michal Karas,Lukas Stejskal,Eduard Cmunt,Olga Cerna, Dana Srbova, Hana Zizkova,Lucia Vrablova,Ivana Skoumalova,Jaroslava Voglova, Tereza Jurkova,Marika Chrapava,Tomas Jurcek,Ivana Jeziskova,Marie Jarosova, Katerina Machova Polakova,Tomas Papajik,Pavel Zak,Pavel Jindra,Daniela Zackova

AMERICAN JOURNAL OF HEMATOLOGY（2024）

引用 0|浏览9

暂无评分

摘要

Overall survival of patients classified according to the European LeukemiaNet 2020 classification. Chronic phase (CP), accelerated phase (AP), blast crisis (BC), low risk (LR), intermediate risk (IR), high risk (HR).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要